Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (FY)Nov 30, 2025 | (Q4)Nov 30, 2025 | (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -70.97%-1.32M | -215.99%-89.65K | -764.25%-867.43K | 64.70%-324.73K | 36.37%-38.15K | 28.29%-772.04K | 185.52%77.3K | 152.34%130.59K | -170.10%-919.96K | 84.86%-59.96K |
| Net income from continuing operations | -66.96%-2.81M | -522.57%-1.64M | -67.59%-426.02K | 43.40%-460.99K | 20.13%-279.83K | 64.97%-1.68M | 88.47%-263.9K | 81.62%-254.2K | -134.53%-814.4K | 55.33%-350.38K |
| Operating gains losses | ---74.97K | ---8.45K | --0 | --0 | ---66.52K | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -20.23%1.09K | -20.23%272 | -20.23%272 | -20.23%272 | -20.23%272 | -19.95%1.36K | -19.95%341 | -19.95%341 | -19.95%341 | -19.95%341 |
| Asset impairment expenditure | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Unrealized gains and losses of investment securities | 9,744.09%110.75K | 27,542.93%205.82K | -5,162.30%-151.87K | 8,514.13%31.55K | 3,465.33%25.24K | -85.00%1.13K | -120.00%-750 | 300.00%3K | -116.67%-375 | -200.00%-750 |
| Remuneration paid in stock | 242.09%1.17M | --948.69K | --0 | -25.54%223.15K | --0 | -25.27%342.55K | --0 | --0 | --299.69K | -81.07%42.86K |
| Other non cashItems | --49.5K | --0 | --0 | --0 | --49.5K | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -59.06%231.64K | 19.14%406.98K | -175.98%-289.82K | 70.70%-118.72K | -5.96%233.2K | 0.95%565.81K | -13.41%341.61K | 318.33%381.45K | -10,317.40%-405.22K | 250.26%247.97K |
| -Change in receivables | -95.13%10.73K | -76.22%63.97K | -3,472.12%-53.3K | 114.17%9.98K | -142.84%-9.93K | 252.07%220.21K | 1,036.46%268.99K | 96.54%-1.49K | -271.71%-70.46K | 142.90%23.17K |
| -Change in prepaid assets | 104.77%2.09K | -36.83%57.35K | -221.46%-45.75K | 78.21%-37.79K | 2,193.43%28.28K | -125.07%-43.71K | 661.56%90.78K | 196.71%37.67K | -412.91%-173.39K | -98.69%1.23K |
| -Change in payables and accrued expense | -3.37%219.27K | 1,198.85%282.23K | -154.85%-190.54K | 50.07%-81.05K | 208.87%208.64K | -53.71%226.91K | -106.93%-25.68K | 185.66%347.39K | -399.69%-162.35K | 121.92%67.55K |
| -Change in other working capital | -100.28%-449 | -54.33%3.44K | 89.04%-232 | -1,114.40%-9.86K | -96.02%6.21K | 298.56%162.4K | --7.53K | ---2.12K | --972 | --156.02K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -70.97%-1.32M | -215.99%-89.65K | -764.25%-867.43K | 64.70%-324.73K | 36.37%-38.15K | 28.29%-772.04K | 185.52%77.3K | 152.34%130.59K | -170.10%-919.96K | 84.86%-59.96K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -12.80%-853.56K | -228.94%-210.07K | -144.66%-417.98K | 32.49%-244.43K | 111.83%18.92K | 5.99%-756.7K | -16.40%-63.86K | 1.56%-170.84K | -4.38%-362.05K | 30.34%-159.94K |
| Net PPE purchase and sale | --121.69K | --0 | --13.69K | --0 | --108K | --0 | --0 | --0 | --0 | --0 |
| Net investment purchase and sale | --9.7K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other investing changes | -30.16%-984.95K | -244.13%-219.77K | -152.68%-431.67K | 32.49%-244.43K | 44.31%-89.08K | 11.48%-756.7K | 39.10%-63.86K | 1.56%-170.84K | -4.38%-362.05K | 30.34%-159.94K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -12.80%-853.56K | -228.94%-210.07K | -144.66%-417.98K | 32.49%-244.43K | 111.83%18.92K | 5.99%-756.7K | -16.40%-63.86K | 1.56%-170.84K | -4.38%-362.05K | 30.34%-159.94K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 784.34%13.72M | 8.07M | 4.47M | -8.23%1.18M | 0 | 27.02%1.55M | 0 | 0 | 1.28M | -77.81%271.08K |
| Net common stock issuance | 690.89%13.17M | --7.65M | --4.3M | -11.66%1.22M | --0 | --1.66M | --0 | --0 | --1.38M | --289.37K |
| Proceeds from stock option exercised by employees | --1.49M | --934.33K | --521.03K | ---- | ---- | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | -728.82%-937.66K | ---512.8K | ---347.52K | ---- | ---- | ---113.13K | --0 | --0 | ---94.84K | ---18.29K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 784.34%13.72M | --8.07M | --4.47M | -8.23%1.18M | --0 | 27.02%1.55M | --0 | --0 | --1.28M | -77.81%271.08K |
| Net cash flow | ||||||||||
| Beginning cash position | 122.58%41.51K | 13,494.88%3.82M | 819.48%628.28K | -68.08%22.29K | 122.58%41.51K | -97.25%18.65K | -82.87%28.08K | -88.36%68.33K | -94.52%69.83K | -97.25%18.65K |
| Current changes in cash | 50,411.23%11.55M | 57,760.43%7.77M | 8,023.91%3.19M | 40,634.85%606K | -137.57%-19.23K | 103.46%22.86K | 109.25%13.43K | 90.49%-40.25K | 99.78%-1.5K | -91.41%51.17K |
| End cash Position | 27,817.50%11.59M | 27,817.50%11.59M | 13,494.88%3.82M | 819.48%628.28K | -68.08%22.29K | 122.58%41.51K | 122.58%41.51K | -82.87%28.08K | -88.36%68.33K | -94.52%69.83K |
| Free cash from | -70.97%-1.32M | -215.99%-89.65K | -764.25%-867.43K | 64.70%-324.73K | 36.37%-38.15K | 28.29%-772.04K | 185.52%77.3K | 152.34%130.59K | -170.10%-919.96K | 84.86%-59.96K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.